Abstract:Graphical representation depicting the potential mechanism involved in FGF10‐mediated protection against AD‐like symptoms and pathologies in both in vivo 3xTg‐AD mice and in vitro APPswe‐transfected HT22 cells. The neuroprotective effects of FGF10 were tested via intranasal delivery and AAV9‐mediated systemic gene delivery methods. FGF10 stimulates the FGFR2/PI3K/AKT signaling pathway, leading to the upregulation of p‐GSK3β S9/GSK3β and Bcl‐2/Bax. This, in turn, reduces tau hyperphosphorylation and neuronal apoptosis, resulting in protection against neuronal damage and cognitive dysfunction in AD. Alzheimer's disease (AD) is characterized with senile plaques formed by Aβ deposition, and neurofibrillary tangles composed of hyperphosphorylated tau protein, which ultimately lead to cognitive impairment. Despite the heavy economic and life burdens faced by the patients with AD, effective treatments are still lacking. Previous studies have reported the neuroprotective effects of FGF10 in CNS diseases, but its role in AD remains unclear. In this study, we demonstrated that FGF10 levels were reduced in the serum of AD patients, as well as in the brains of 3xTg‐AD mice and APPswe‐transfected HT22 cells, suggesting a close relationship between FGF10 and AD. Further investigations revealed that intranasal delivery of FGF10 improved cognitive functions in 3xTg‐AD mice. Additionally, FGF10 treatment reduced tau hyperphosphorylation and neuronal apoptosis, thereby mitigating neuronal cell damage and synaptic deficits in the cortex and hippocampus of 3xTg‐AD mice, as well as APPswe‐transfected HT22 cells. Furthermore, we evaluated the therapeutic potential of FGF10 gene delivery for treating AD symptoms and pathologies. Tail vein delivery of the FGF10 gene using AAV9 improved cognitive and neuronal functions in 3xTg‐AD mice. Similarly, endogenous FGF10 overexpression ameliorated tau hyperphosphorylation and neuronal apoptosis in the cortex and hippocampus of 3xTg‐AD mice. Importantly, we confirmed that the FGFR2/PI3K/AKT signaling pathway was activated following intranasal FGF10 delivery and AAV9‐mediated FGF10 gene delivery in 3xTg‐AD mice and APPswe‐transfected HT22 cells. Knockdown of FGFR2 attenuated the protective effect of FGF10. Collectively, these findings suggest that intranasal delivery of FGF10 and AAV9‐mediated FGF10 gene delivery could be a promising disease‐modifying therapy for AD.

Neuroprotective Effects of LMW and HMW FGF2 Against Amyloid Beta Toxicity in Primary Cultured Hippocampal Neurons.

Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity

A method for the expression of fibroblast growth factor 14 and assessment of its neuroprotective effect in an Alzheimer's disease model

Protective effect of EGb761 against Aβ1-42 -induced SHSY5Y cells injury and blood-brain barrier disruption via regulating Akt/Nrf2 signaling pathway

FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders

Effects of nerve growth factor on Aβ23-35-induced hippocampal neuron injury

Function and Mechanism of Polygalasaponin F on Amyloid β Protein-induced Damage in Mice

Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection

Protective Effect of S14G-humanin Against Beta-Amyloid Induced LTP Inhibition in Mouse Hippocampal Slices.

Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice

Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis

Inhibition of Tumor Necrosis Factor-Alpha by Sodium Ferulate in Protecting Neurons from Beta-Amyloid Induced Damage

Modulation of the Astrocyte-Neuron Lactate Shuttle System Contributes to Neuroprotective Action of Fibroblast Growth Factor 21.

BV2 Membrane-Coated PEGylated-Liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy

Fibroblast Growth Factor 21 Ameliorates Neurodegeneration in Rat and Cellular Models of Alzheimer’s Disease

INFLUENCE OF FIBROBLAST GROWTH FACTOR-2 ON THE ACTIVATION OF MOUSE HIPPOCAMPAL MICROGLIA IN A LIPOPOLYSACCHARIDE-INDUCED NEUROINFLAMMATION MODEL IN VITRO

FGF-2 Regulates Neurogenesis and Degeneration in the Dentate Gyrus after Traumatic Brain Injury in Mice

Brain-derived Neurotrophic Factor Ameliorates Learning Deficits in a Rat Model of Alzheimer's Disease Induced by Aβ1-42.

Effect of humanin and [Gly14]-humanin on expression of hippocampal glial fibrillary acidic protein in mice with Alzheimer disease

Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.

Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer's disease